Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sickle ß0-Thalassemia”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Study completedNCT01179217
What this trial is testing

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Who this might be right for
Sickle Cell AnemiaSickle ß0-Thalassemia
Emmaus Medical, Inc. 230
Testing effectiveness (Phase 2)Study completedNCT00125788
What this trial is testing

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

Who this might be right for
Sickle Cell AnemiaThalassemia
Emmaus Medical, Inc. 70
Testing effectiveness (Phase 2)Ended earlyNCT00586209
What this trial is testing

L-Glutamine Therapy for Sickle Cell Anemia

Who this might be right for
Sickle Cell AnemiaThalassemia
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 15

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation